All In Biotech

Drug Trial Radar · NCT03042416

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

Last checked: Nov 19, 2026Latest source record: Jan 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

400

Actual

Start

Jun 29, 2017

Primary completion

Mar 5, 2021

Study completion Jun 2, 2021

Sponsor

Lead sponsor
University of AlbertaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Alberta Health services
First posted
Feb 3, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single centre prospective cohort phase III study of 18F-DOPA PET/CT imaging in specific patient populations: 1. Pediatric patients with congenital hyperinsulinism 2. Pediatric patients with neuroblastoma 3. Pediatric or Adult patients with suspected extra-pancreatic neuroendocrine tumor 4. Adult patients with a clinical suspicion of Parkinson's disease 5. Pediatric or Adult patients with primary brain tumors This study will evaluate the biodistribution and safety of 18F-DOPA produced at the Edmonton PET Centre.

Conditions

  • Congenital Hyperinsulinism
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Parkinson Disease
  • Brain Glioma

Interventions

  • 18F-DOPADrug

    18F-DOPA intravenous injection single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Immediate safety evaluationTime frame: Within 1 hour of injection

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.